Clinical trial NCT05555459: Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation
Official title: The Performance and Safety Evaluation of Bioabsorbable Headless Inion CompressOn Screws in Selected Fracture, Osteotomy and Artrodesis Surgeries of the Foot and Ankle
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Medial Malleolus Fracture
Lisfranc Injury
Lisfranc Fracture
Talus Fracture
Calcaneus Fracture
Navicular Fracture
Deformity, Foot
Ankle Fractures
Foot Fracture
Fractures, Bone
Fracture of Foot
Foot Deformities
Foot Injury
Feet Deformity Tarsus
Metatarsalgia
Hallux Rigidus
Hallux Valgus
Deformity of Toe
Deformity of Foot
Keywords: bioabsorbable screw
compression screw
headless screw
orthopaedic screw
bone fixation
bioabsorbable screw study
resorbable
biodegradable
bioabsorbable
fracture fixation with resorbable implants
inion
post-market follow-up study
orthopedic bone fixation
arthrodesis
osteotomy
Lead sponsor: Inion Oy
Sponsor class: INDUSTRY
First posted: 2022-09-26
Enrollment: 125
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: A single group study including 125 adult patient participants. All patients undergo a bone fixation surgical operation in foot/ankle area. Indications are specified in the study description. All operations are performed in the one study center using Inion CompressOn screws.
Primary purpose: TREATMENT

Brief summary: The study in question is a post market clinical follow up (PMCF) study to evaluate the safety and performance of bioabsorbable headless compression screw Inion CompressOn in selected fracture, osteotomy and arthrodeses operations of the foot and ankle. The study recruits 125 adult patients who meet the acceptance criteria. The follow-up time for each study patient is 4 years. The study is a single center single group study which is conducted in Tampere University Hospital (TAYS) in Finland. The main focus of the study in terms of performance is to evaluate the bone healing/ossification of operated areas. The main focus of the study in terms of safety is to evaluate the occurrence of adverse events and required revision surgeries that are or might be related to the study device.

Detailed description: The study in question is a post market clinical follow-up study to evaluate the safety and performance of bioabsorbable headless compression screw Inion CompressOn in selected fracture, osteotomy and arthrodeses operations of the foot and ankle. The main focus of the study in terms of performance is to evaluate the bone healing/ossification of operated areas. The main focus of the study in terms of safety is to evaluate the occurrence of adverse events and required revision surgeries that are or might be related to the study device.

The Inion CompressOn™ screws are cannulated headless compression screws made of degradable co-polymers composed of L-lactic acid and D-lactic acid. These polymers have a long history of safe medical use and they degrade in vivo by hydrolysis into alpha-hydroxy acids that are metabolised by the body. The screws retain their initial strength up to 12 weeks after implantation and gradually lose their strength thereafter. Bioabsorption takes place within two to four years. The Inion CompressOn™ products are intended for maintenance of alignment and fixation of bone fractures, comminuted fractures, osteotomies, arthrodeses or bone grafts (i.e., autografts or allografts) in the presence of appropriate additional immobilization (e.g., rigid fixation implants, cast or brace).

In the field of foot and ankle traumatology the surgical indications of this study include medial malleolar fractures, Lisfranc injuries, talus fractures, calcaneal fractures and navicular bone fractures. In the field of foot and ankle orthopaedics the surgical indications of the study include arthrodesis of the talonavicular joint, calcaneacuboideal joint, tarsometatarsal joint and first metatarsophalangeal (MTP1) joint, and osteotomies of the first metatarsal bone, second metatarsal bone (weil) and calcaneal bone.

The clinical data collection acquired from this study is a requirement of the EU Notified Body as part of the admitted CE mark certification, in cases when the device is initially approved based on the clinical data of an equivalent device. In this case, the equivalent device has been Inion FreedomScrew, which is made of the same material composition and has the same indications for use. Inion CompressOn Screw has new design features such as headless design, and threading which allows compression to the fracture line. Also new sizes are introduced.

The study recruits 125 adult patients who meet the acceptance criteria and have signed the informed consent. The follow-up time for each study patient is 4 years. Each patient has 6 follow-up time points related to the study. These time points consist of:

1. screening visit (-180-0 days before operation),
2. operation (day 0),
3. post-operative follow-up 1 (6 weeks after operation +/- 1 week),
4. post-operative follow-up 2 (3 months after operation +/- 2 weeks),
5. post-operative follow-up 3 (2 years after operation +/- 2 months)
6. post-operative follow-up 4 (4 years after operation +/- 4 months) The first 4 time points are within standard care, the last 2 time points (post-operative follow-up 3 and post-operative follow-up 4) are scheduled for study purposes only to be able to gain performance and safety data based on adequate follow-up time.

The study is a single center single group study which is conducted in Tampere University Hospital (TAYS) in Finland.

Eligibility criteria: Inclusion Criteria:

1. Read the patient information bulletin on the study and signed the patient consent form
2. Adult patient (over 18-year-old)
3. Suitable and in need for surgical lower limb operation listed in the indications of this study that requires fastening of bone structures with screws (or an alternative attachment method) in the ankle or foot area, according to a statement of the investigator surgeon
4. Ability to fill in questionnaires.
5. Willingness to comply with rehabilitation instructions.
6. Availability for follow-up visits.

Exclusion Criteria:

1. Active infection
2. Patient conditions including limited blood supply (e.g. patients with severe circulatory disorder of the lower limb
3. Patient conditions including insufficient quality or quantity of bone (diagnosed osteoporosis, conditions causing secondary osteoporosis e.g. diabetes, rheumatism, eating disorder)
4. Patient conditions where patient cooperation cannot be guaranteed (alcohol use, drug abuse etc.)
5. High-load bearing indications (e.g., diaphyseal fractures of long bones) unless used in conjunction with traditional rigid fixation
6. Patients with significant neuropathy
7. Pregnancy
8. Patients who refuse to participate
9. Lower limb tumor or metastasis
10. Complex Regional Pain Syndrome (CRPS) in operated foot

Primary outcomes:
measure: Bone healing (ossification) of the fracture, osteotomy and arthrodesis lines
timeFrame: Change from operation to 4 years
measure: Occurrence of adverse events (AEs)
timeFrame: During 4-year follow-up
measure: Occurrence of revision surgeries
timeFrame: During 4-year follow-up
Secondary outcomes:
measure: Subjective functionality of the operated foot or ankle (VAS foot and ankle)
timeFrame: Change from baseline to 4 years
measure: Subjective functionality of the operated foot or ankle (EFAS)
timeFrame: Change from baseline to 4 years
measure: Wound and soft tissue healing
timeFrame: Change from operation to 3 months
measure: Fixation strength
timeFrame: Change from operation to 4 years
measure: Bone formation in screw tunnel
timeFrame: Change from operation to 4 years
Other outcomes:
Locations:
city: Tampere
country: Finland
facility: Tampere University Hospital
Study officials:
affiliation: Tampere University Hospital
name: Mäenpää
role: PRINCIPAL_INVESTIGATOR
References: